logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Cisplatin/gemcitabine/pembrolizumabLack of efficacy and asymptomatic hypothyroidism: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1930卷 / 1期
关键词:
D O I:
10.1007/s40278-022-26456-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:193 / 193
相关论文
共 50 条
  • [31] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2025, 2041 (1) : 330 - 330
  • [32] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1900 (1) : 274 - 274
  • [33] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1924 (1) : 366 - 366
  • [34] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2024, 2035 (1) : 416 - 416
  • [35] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1919 (1) : 495 - 495
  • [36] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1946 (1) : 457 - 457
  • [37] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2021, 1844 (1) : 367 - 367
  • [38] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1910 (1) : 393 - 393
  • [39] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1978 (1) : 314 - 314
  • [40] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2024, 2030 (1) : 420 - 420
← 12345 →